These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10425689)

  • 1. PCR testing of plasma pools: from concept to reality.
    Flanagan P; Barbara J
    Transfus Med Rev; 1999 Jul; 13(3):164-76. PubMed ID: 10425689
    [No Abstract]   [Full Text] [Related]  

  • 2. Assays for viral sequences and their value in validation of viral elimination.
    Saldanha J
    Dev Biol Stand; 1993; 81():231-6. PubMed ID: 8174807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction of the gene amplification technique to decrease the risk of hepatitis C virus transmission by plasma products.
    Branović K; Forcis D; Kosutic-Gulija T; Santak M; Zgorelec R; Mazuran R
    J Chromatogr A; 1999 Aug; 852(1):305-12. PubMed ID: 10480255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of hepatitis C virus from mothers with chronic hepatitis C without human immunodeficiency virus.
    Kuroki T; Nishiguchi S; Fukuda K; Nakajima S; Shiomi S; Murata R; Isshiki G; Kobayashi K
    J Infect Dis; 1992 Nov; 166(5):1192-3. PubMed ID: 1328406
    [No Abstract]   [Full Text] [Related]  

  • 5. Implementation of an 'in-house' PCR assay validated for the detection of hepatitis C virus RNA.
    Lombardi GR; Oviedo A; Freytes F; Zarzur J; Guglielmone H; Vitali MS
    Transfus Med; 2008 Oct; 18(5):317-9. PubMed ID: 18937742
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of working reagents and international standards.
    Saldanha J
    Biologicals; 1998 Jun; 26(2):115-7. PubMed ID: 9811516
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the diagnostic efficacy of a test system for detecting hepatitis virus C RNA by polymerase chain reaction "AmpliSens(TM) HCV-240/BKO-440)"].
    Bektimirov TA; Volkova RA; El'bert EV; Shalunova NV; Chulanov VP; Gorbunov MA; Nikitiuk NM; Shipulin GA; Shipulina OIu; Bocharova NG; Musina EE
    Vopr Virusol; 2002; 47(5):12-6. PubMed ID: 12522962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCR detects HCV RNA in a plasma pool contaminated by a single preseroconversion donation of genotype 5a.
    Thomas I; Branckaert T; Mathys E; Vranckx R; Laub R
    Vox Sang; 2000; 79(2):69-71. PubMed ID: 11054042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of polymerase chain reaction for detection of hepatitis C virus.
    Zaaijer HL; Cuypers HT; Reesink HW; Winkel IN; Gerken G; Lelie PN
    Lancet; 1993 Mar; 341(8847):722-4. PubMed ID: 8095626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus-polymerase chain reaction minipool testing: 3 years in the largest Swiss blood transfusion service.
    Stolz M; Gilgen M; Niederhauser C
    Vox Sang; 2003 Feb; 84(2):105-10. PubMed ID: 12609016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus blood donor screening: recombinant immunoblot assay interpretation re-examined.
    Perrons CJ; Garson JA
    Vox Sang; 1993; 64(4):253. PubMed ID: 7685973
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C virus infection and chronic active myocarditis.
    Kao JH; Hwang JJ
    Circulation; 1998 Sep; 98(10):1044-5. PubMed ID: 9737529
    [No Abstract]   [Full Text] [Related]  

  • 13. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.
    Roth WK; Weber M; Seifried E
    Lancet; 1999 Jan; 353(9150):359-63. PubMed ID: 9950441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of third-generation screening and confirmatory assays for HCV antibodies.
    Uyttendaele S; Claeys H; Mertens W; Verhaert H; Vermylen C
    Vox Sang; 1994; 66(2):122-9. PubMed ID: 7514324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International collaborative study on the second EUROHEP HCV-RNA reference panel.
    Damen M; Cuypers HT; Zaaijer HL; Reesink HW; Schaasberg WP; Gerlich WH; Niesters HG; Lelie PN
    J Virol Methods; 1996 Apr; 58(1-2):175-85. PubMed ID: 8783163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus and intravenous anti-D immunoglobulin.
    Commun Dis Rep CDR Wkly; 1995 Jun; 5(24):111, 114. PubMed ID: 7542122
    [No Abstract]   [Full Text] [Related]  

  • 17. Including polymerase chain reaction in screening for hepatitis C virus RNA in blood donations is not cost-effective.
    Loubière S; Rotily M; Durand-Zaleski I; Costagliola D
    Vox Sang; 2001 May; 80(4):199-204. PubMed ID: 11438026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborative study to assess the suitability of an HCV RNA reference sample for detection of an HCV RNA in plasma pools by PCR.
    Saldanha J; Minor P
    Vox Sang; 1996; 70(3):148-51. PubMed ID: 8740006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of hepatitis C virus RNA polymerase chain reaction through a multicentre quality control study. French Study Group for the Standardization of Hepatitis C Virus PCR.
    J Virol Methods; 1994 Aug; 49(1):79-88. PubMed ID: 7829594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Real-time" polymerase chain reaction.
    Oldach D
    Gastroenterology; 1999 Mar; 116(3):763-4. PubMed ID: 10029634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.